294 related articles for article (PubMed ID: 28589744)
41. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies.
Forouhi NG; Ye Z; Rickard AP; Khaw KT; Luben R; Langenberg C; Wareham NJ
Diabetologia; 2012 Aug; 55(8):2173-82. PubMed ID: 22526608
[TBL] [Abstract][Full Text] [Related]
42. Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies.
Feng Q; Zhang H; Dong Z; Zhou Y; Ma J
Medicine (Baltimore); 2017 Nov; 96(45):e8613. PubMed ID: 29137092
[TBL] [Abstract][Full Text] [Related]
43. Vitamin D Food Fortification and Biofortification Increases Serum 25-Hydroxyvitamin D Concentrations in Adults and Children: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dunlop E; Kiely ME; James AP; Singh T; Pham NM; Black LJ
J Nutr; 2021 Sep; 151(9):2622-2635. PubMed ID: 34113994
[TBL] [Abstract][Full Text] [Related]
44. Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.
Palmer JR; Gerlovin H; Bethea TN; Bertrand KA; Holick MF; Ruiz-Narvaez EN; Wise LA; Haddad SA; Adams-Campbell LL; Kaufman HW; Rosenberg L; Cozier YC
Breast Cancer Res; 2016 Aug; 18(1):86. PubMed ID: 27520657
[TBL] [Abstract][Full Text] [Related]
45. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors.
Sheean P; Arroyo C; Woo J; Schiffer L; Stolley M
J Acad Nutr Diet; 2018 Apr; 118(4):568-577. PubMed ID: 29305131
[TBL] [Abstract][Full Text] [Related]
47. Association between serum concentration of vitamin D and 1-year mortality in stroke patients.
Daubail B; Jacquin A; Guilland JC; Khoumri C; Aboa-Eboulé C; Giroud M; Béjot Y
Cerebrovasc Dis; 2014; 37(5):364-7. PubMed ID: 24970287
[TBL] [Abstract][Full Text] [Related]
48. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
49. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF
Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542
[TBL] [Abstract][Full Text] [Related]
50. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.
Schöttker B; Herder C; Rothenbacher D; Perna L; Müller H; Brenner H
Eur J Epidemiol; 2013 Mar; 28(3):267-75. PubMed ID: 23354985
[TBL] [Abstract][Full Text] [Related]
51. Circulating 25-hydroxyvitamin D level and prognosis of lung cancer patients: A systematic review and meta-analysis.
Huang JD; Dong CH; Shao SW; Gu TJ; Hu ZL; Ying J; Zhou DF; Xie YP
Bull Cancer; 2017; 104(7-8):675-682. PubMed ID: 28587766
[TBL] [Abstract][Full Text] [Related]
52. Meta-analysis: serum vitamin D and breast cancer risk.
Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
Eur J Cancer; 2010 Aug; 46(12):2196-205. PubMed ID: 20456946
[TBL] [Abstract][Full Text] [Related]
53. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer.
Mohr SB; Gorham ED; Kim J; Hofflich H; Garland CF
Anticancer Res; 2014 Mar; 34(3):1163-6. PubMed ID: 24596354
[TBL] [Abstract][Full Text] [Related]
54. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.
Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1339-43. PubMed ID: 18559548
[TBL] [Abstract][Full Text] [Related]
55. Serum 25(OH)D response to vitamin D3 supplementation: a meta-regression analysis.
Shab-Bidar S; Bours S; Geusens PP; Kessels AG; van den Bergh JP
Nutrition; 2014 Sep; 30(9):975-85. PubMed ID: 24993750
[TBL] [Abstract][Full Text] [Related]
56. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
57. The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies.
Shen Y; Xia J; Yi C; Li T; Wang P; Dai L; Shi J; Wang K; Sun C; Ye H
Eur J Nutr; 2024 Apr; 63(3):653-672. PubMed ID: 38170272
[TBL] [Abstract][Full Text] [Related]
58. Acute Respiratory Tract Infection and 25-Hydroxyvitamin D Concentration: A Systematic Review and Meta-Analysis.
Pham H; Rahman A; Majidi A; Waterhouse M; Neale RE
Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31438516
[TBL] [Abstract][Full Text] [Related]
59. Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis.
Zhang L; Zou H; Zhao Y; Hu C; Atanda A; Qin X; Jia P; Jiang Y; Qi Z
BMJ Open; 2019 Dec; 9(12):e030513. PubMed ID: 31874870
[TBL] [Abstract][Full Text] [Related]
60. Vitamin D and liver cancer risk: A meta-analysis of prospective studies.
Guo XF; Zhao T; Han JM; Li S; Li D
Asia Pac J Clin Nutr; 2020; 29(1):175-182. PubMed ID: 32229457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
